These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37624910)

  • 1. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
    Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
    Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
    Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
    Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.
    Chen Z; Ji Z; Ngiow SF; Manne S; Cai Z; Huang AC; Johnson J; Staupe RP; Bengsch B; Xu C; Yu S; Kurachi M; Herati RS; Vella LA; Baxter AE; Wu JE; Khan O; Beltra JC; Giles JR; Stelekati E; McLane LM; Lau CW; Yang X; Berger SL; Vahedi G; Ji H; Wherry EJ
    Immunity; 2019 Nov; 51(5):840-855.e5. PubMed ID: 31606264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours.
    Ni L
    Clin Transl Med; 2024 Aug; 14(8):e1817. PubMed ID: 39169517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS limits memory-like properties and function of exhausted PD-1
    Humblin E; Korpas I; Prokhnevska N; Vaidya A; Lu J; van der Heide V; Filipescu D; Bobrowski T; Marks A; Park MD; Bernstein E; Brown BD; Lujambio A; Dominguez-Sola D; Rosenberg BR; Kamphorst AO
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
    Kamphorst AO; Wieland A; Nasti T; Yang S; Zhang R; Barber DL; Konieczny BT; Daugherty CZ; Koenig L; Yu K; Sica GL; Sharpe AH; Freeman GJ; Blazar BR; Turka LA; Owonikoko TK; Pillai RN; Ramalingam SS; Araki K; Ahmed R
    Science; 2017 Mar; 355(6332):1423-1427. PubMed ID: 28280249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB2 regulates the differentiation and stemness of exhausted CD8
    Neubert EN; DeRogatis JM; Lewis SA; Viramontes KM; Ortega P; Henriquez ML; Buisson R; Messaoudi I; Tinoco R
    Nat Commun; 2023 Sep; 14(1):5631. PubMed ID: 37704621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
    Tsui C; Kretschmer L; Rapelius S; Gabriel SS; Chisanga D; Knöpper K; Utzschneider DT; Nüssing S; Liao Y; Mason T; Torres SV; Wilcox SA; Kanev K; Jarosch S; Leube J; Nutt SL; Zehn D; Parish IA; Kastenmüller W; Shi W; Buchholz VR; Kallies A
    Nature; 2022 Sep; 609(7926):354-360. PubMed ID: 35978192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
    Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
    Front Immunol; 2022; 13():869768. PubMed ID: 35774790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response.
    Wills MR; Okecha G; Weekes MP; Gandhi MK; Sissons PJ; Carmichael AJ
    J Immunol; 2002 Jun; 168(11):5455-64. PubMed ID: 12023339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
    Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
    Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor progenitor exhausted CD8
    Lan X; Mi T; Alli S; Guy C; Djekidel MN; Liu X; Boi S; Chowdhury P; He M; Zehn D; Feng Y; Youngblood B
    Nat Immunol; 2024 Jun; 25(6):1046-1058. PubMed ID: 38816618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 19. Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.
    Fröhlich M; Gogishvili T; Langenhorst D; Lühder F; Hünig T
    Eur J Immunol; 2016 Jul; 46(7):1644-55. PubMed ID: 27122236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precursor exhausted CD8
    Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
    Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.